University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 22 of 24
Dynasplint Therapy for Trismus in Head and Neck Cancer
NCT00507208
Implantable Antenna Sensors for Continuous Glucose Monitoring
NCT00596323
Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bariatric Surgery Patients
NCT00473356
Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
NCT00562003
Inflammatory Cytokine Variations in Traumatic Injury Responses
NCT00593892
Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients
NCT00583869
Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates
NCT00599053
Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM
NCT00476788
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults
NCT02442479
The Effect of Sedation on Eye Movements
NCT00646646
Intramuscular Lipid and Insulin Action:Ethnic Aspects
NCT00726908
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
NCT00539942
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
NCT00703196
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
NCT00446862
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
NCT00473564
Vitamin D Deficiency in Obese Adolescent Girls and Influence of Vitamin D on Insulin Secretion and Sensitivity
NCT00850694
The Use of RIA to Harvest Bone Graft for Treatment of Non-unions and Fractures
NCT00582439
A Study to Evaluate Associations Between Gingivitis and Pregnancy Outcomes
NCT00641901
A Study to Identify Markers in Blood and Tissue of HPV Clearance
NCT00711815
Randomized, Prospective Comparison of Two Femoral Reaming Systems
NCT00594438
Randomized Clinical Trial of Bifocal Lenses Versus Computer-specific Progressive Addition Lenses
NCT00585026
Reading Fluency and Accommodative Lag
NCT00383175
A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
NCT00369512
Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
NCT00294658
An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)
NCT00721565
Genetic and Physical Characteristics of Rett Syndrome
NCT00299312
A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
NCT00584909
Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis
NCT00294125
Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia
NCT00584129
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
NCT00584935
Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture
NCT00290199
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
NCT00335114
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
NCT00317434
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
NCT00240071
Determinants of Compliance With Glaucoma Therapy
NCT00362622
Constraint-Induced Therapy Modified for Rehabilitating Arm Function in Stroke Survivors w/Plegic Hands
NCT00366210
The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)
NCT00599040
Impact of Diabetes on Left Ventricular Remodeling
NCT01052272
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer
NCT00322920
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
NCT00161291
Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)
NCT00240097
Molecular Mechanisms of Mitral Regurgitation-Aim 2
NCT01052532
Internet Intervention to Improve Rural Diabetes Care
NCT00403091
Evaluation of the ACE Dental Implant
NCT00641576
A Phase II Study of Spinal Radiosurgery
NCT00573872
Effects of Medium Chain Triglyceride Oil, Versus Olive Oil, for Weight Loss
NCT00529919
ADAPT-Altering Diet for African American Populations to Treat Hypertension
NCT00621569
Treatment of Bacterial Vaginosis (BV) With Tinidazole
NCT00334633
Multimodal Physician Intervention to Detect Amblyopia
NCT01109459
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
NCT01052428
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.